BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 26416911)

  • 1. Differential influence of nutrient-starved Mycobacterium tuberculosis on adaptive immunity results in progressive tuberculosis disease and pathology.
    Dietrich J; Roy S; Rosenkrands I; Lindenstrøm T; Filskov J; Rasmussen EM; Cassidy J; Andersen P
    Infect Immun; 2015 Dec; 83(12):4731-9. PubMed ID: 26416911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective CD4 T cells targeting cryptic epitopes of Mycobacterium tuberculosis resist infection-driven terminal differentiation.
    Woodworth JS; Aagaard CS; Hansen PR; Cassidy JP; Agger EM; Andersen P
    J Immunol; 2014 Apr; 192(7):3247-58. PubMed ID: 24574499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of CD4+ CD25+ regulatory T cells during early mycobacterial infection increases cytokine production but does not affect pathogen load.
    Quinn KM; McHugh RS; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
    Immunol Cell Biol; 2006 Oct; 84(5):467-74. PubMed ID: 16869940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis.
    Hölscher C; Hölscher A; Rückerl D; Yoshimoto T; Yoshida H; Mak T; Saris C; Ehlers S
    J Immunol; 2005 Mar; 174(6):3534-44. PubMed ID: 15749890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD11c(+)  CD103(+) cells of Mycobacterium tuberculosis-infected C57BL/6 but not of BALB/c mice induce a high frequency of interferon-γ- or interleukin-17-producing CD4(+) cells.
    Sérgio CA; Bertolini TB; Gembre AF; Prado RQ; Bonato VL
    Immunology; 2015 Apr; 144(4):574-86. PubMed ID: 25322675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
    Sugawara I; Udagawa T; Taniyama T
    Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity and efficacy of dendritic cell-based vaccination against tuberculosis with complex mycobacterial antigens in a mouse model.
    Rubakova E; Petrovskaya S; Pichugin A; Khlebnikov V; McMurray D; Kondratieva E; Baturina I; Kondratieva T; Apt A
    Tuberculosis (Edinb); 2007 Mar; 87(2):134-44. PubMed ID: 17011827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological functions of Mycobacterium tuberculosis-specific CD4+T cells were impaired by tuberculosis pleural fluid.
    Li Q; Li L; Liu Y; Fu X; Wang H; Lao S; Yang B; Wu C
    Immunol Lett; 2011 Aug; 138(2):113-21. PubMed ID: 21549757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary mucosal immunity mediated through CpG provides adequate protection against pulmonary Mycobacterium tuberculosis infection in the mouse model. A role for type I interferon.
    Troy A; Esparza-Gonzalez SC; Bartek A; Creissen E; Izzo L; Izzo AA
    Tuberculosis (Edinb); 2020 Jul; 123():101949. PubMed ID: 32741537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
    Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
    Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host genetic background affects regulatory T-cell activity that influences the magnitude of cellular immune response against Mycobacterium tuberculosis.
    Paula MO; Fonseca DM; Wowk PF; Gembre AF; Fedatto PF; Sérgio CA; Silva CL; Bonato VL
    Immunol Cell Biol; 2011 May; 89(4):526-34. PubMed ID: 20956987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T Cell Responses against Mycobacterial Lipids and Proteins Are Poorly Correlated in South African Adolescents.
    Seshadri C; Lin L; Scriba TJ; Peterson G; Freidrich D; Frahm N; DeRosa SC; Moody DB; Prandi J; Gilleron M; Mahomed H; Jiang W; Finak G; Hanekom WA; Gottardo R; McElrath MJ; Hawn TR
    J Immunol; 2015 Nov; 195(10):4595-603. PubMed ID: 26466957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood gamma interferon release assays predict lung responses and Mycobacterium tuberculosis disease outcome in mice.
    Beamer GL; Flaherty DK; Vesosky B; Turner J
    Clin Vaccine Immunol; 2008 Mar; 15(3):474-83. PubMed ID: 18184822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
    Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
    PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells.
    Derrick SC; Yabe IM; Yang A; Morris SL
    Vaccine; 2011 Apr; 29(16):2902-9. PubMed ID: 21338678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ expression of CD40, CD40L (CD154), IL-12, TNF-alpha, IFN-gamma and TGF-beta1 in murine lungs during slowly progressive primary tuberculosis.
    Mogga SJ; Mustafa T; Sviland L; Nilsen R
    Scand J Immunol; 2003 Sep; 58(3):327-34. PubMed ID: 12950679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating mycobacterial-reactive CD4+ T cells with an immunosuppressive phenotype are higher in active tuberculosis than latent tuberculosis infection.
    Kim K; Perera R; Tan DB; Fernandez S; Seddiki N; Waring J; French MA
    Tuberculosis (Edinb); 2014 Sep; 94(5):494-501. PubMed ID: 25095750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs.
    Happel KI; Lockhart EA; Mason CM; Porretta E; Keoshkerian E; Odden AR; Nelson S; Ramsay AJ
    Infect Immun; 2005 Sep; 73(9):5782-8. PubMed ID: 16113296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice.
    Nandakumar S; Kannanganat S; Posey JE; Amara RR; Sable SB
    PLoS One; 2014; 9(11):e113951. PubMed ID: 25419982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
    Majlessi L; Simsova M; Jarvis Z; Brodin P; Rojas MJ; Bauche C; Nouzé C; Ladant D; Cole ST; Sebo P; Leclerc C
    Infect Immun; 2006 Apr; 74(4):2128-37. PubMed ID: 16552042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.